2nd Quarter - Report

RED+BLUE STRATEGIES for PEW CHARITABLE TRUSTS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 2182, the Generating Antibiotic Incentives Now Act, in support of innovations in the development of new antibiotics Issues related to upstream and downstream supply chain safety

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2182 (112th)

Health Issues HCR

H.R. 2182, the Generating Antibiotic Incentives Now Act of 2011. Supporting work to increase innovation in the development of new antibiotics. Implementation and rulemaking related to the Physician Payment Sunshine Act as included in the Health Reform Law. Issues related to upstream and downstream drug supply chain safety.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2182 (112th)

Medicare/Medicaid MMM

Implementation and rulemaking related to the Physician Payment Sunshine Act - a Medicare related provision in the health reform law.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.